Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 4:17 AM ET

Pharmaceuticals

Company Overview of Foamix Pharmaceuticals Ltd.

Executive Profile

Rex Bright

External Director, Chairman of Compensation Committee and Member of Audit Committee, Foamix Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
75--

Background

Mr. Rex Bright is a Co-Founder of SkinMedica Inc. Mr. Bright served as the Chief Executive Officer of SkinMedica Inc. from October 2001 to 2008 and served as its President since October 2001. He served as the President of Allergan Skin Care, which he successfully built into a leading skin care company. He spent several years as a start-up and turnaround executive in the health care sector, where he served as President and Chief Executive Officer of several companies ...

Corporate Headquarters

2 Holzman Street
Rehovot, -- 76704

Israel

Phone: 972 8 931 6233
Fax: --

Board Members Memberships

2002-Present
Director
2014-Present
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
2014-Present
External Director, Chairman of Compensation Committee and Member of Audit Committee

Education

BA
Drury University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Barry D. Quart Pharm.D.Chief Executive Officer and Director
Heron Therapeutics, Inc.
$540.8K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Foamix Pharmaceuticals Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.